Immunitybio Inc (IBRX) — Long-term Investment Intensity
Immunitybio Inc (IBRX) has a Long-term Investment Intensity of 0.2% as of December 2023. Long-term investments of $891.00K represent 0.2% of total assets of $504.45 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore IBRX cash generation efficiency to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Immunitybio Inc Long-term Investment Intensity (2020–2023)
This chart shows how Immunitybio Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2020 to 2023. As of December 2023, the intensity stands at 0.2%, reflecting long-term investments of $891.00K against total assets of $504.45 Million USD. Explore how well can Immunitybio Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Immunitybio Inc (2020–2023)
The table below presents the year-by-year Long-term Investment Intensity for Immunitybio Inc from 2020 to 2023, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see IBRX company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.2% | $891.00K | $504.45 Million | ▼ -0.1 pp |
| 2022 | 0.2% | $840.00K | $362.36 Million | ▲ +0.1 pp |
| 2021 | 0.2% | $822.00K | $468.91 Million | ▼ -5.0 pp |
| 2020 | 5.1% | $11.40 Million | $221.38 Million | — |